U.S. Pain Foundation was busy in June with activities surrounding National Migraine & Headache Awareness Month (MHAM). In collaboration with member organizations of CHAMP (Coalition For Headache & Migraine Patients), awareness of headache diseases was elevated.
U.S. Pain hosted two interactive web events, which can be viewed by following the links:
- “Overcoming a brain in pain: Advice from migraine strategist Lindsay Weitzel, PhD,” and
- “What migraine doctors and patients can learn from one another: A conversation with Abby Chua, DO, and Katie Golden.” (Must register to view)
Ambassadors worked to obtain proclamations from their local governments to recognize June as National Migraine & Head Awareness Month. U.S. Pain also helped promote Shades for Migraine, attended the Danielle Byron Henry Foundation’s “Shine Her Light” event in Salt Lake City, and participated in two of Chronic Migraine Awareness, Inc’s “Fact-A-Day” social media posts, and partnered on the start of their newest program, Triage Kits.
Meanwhile, the INvisible Project: Migraine 3rd Edition was distributed at numerous events and meetings, including the National Headache Foundation’s Annual Gala, three Miles for Migraine events, Cure for Cluster’s virtual race (hosted by INvisible Project participant Ashley Hattle-Cleminshaw), United Way’s Purple Passion Migraine Awareness Walk (coordinated by INvisible Project participant Hailey Pushis), and Amgen Pharmaceuticals’ Employee Wellness Day.
Director of State Advocacy, Shaina Smith, kicked off the INvisible Project State Capitol tour in Rhode Island to talk to legislators about the importance of migraine, headache and cluster diseases.
The most exciting news that coincided with MHAM was the Food & Drug Administration’s approval of a brand new class of preventive medications, called CGRP inhibitors, for the indication of episodic cluster headache disease, medically considered as the most painful condition known to man.
U.S. Pain Foundation would like to thank its platinum sponsors, Amgen and Novartis, for their support of its migraine initiatives. In addition, we thank our INvisible Project sponsors: Amgen, Novartis, Teva and Eli Lilly.